JP2013519717A5 - - Google Patents

Download PDF

Info

Publication number
JP2013519717A5
JP2013519717A5 JP2012553390A JP2012553390A JP2013519717A5 JP 2013519717 A5 JP2013519717 A5 JP 2013519717A5 JP 2012553390 A JP2012553390 A JP 2012553390A JP 2012553390 A JP2012553390 A JP 2012553390A JP 2013519717 A5 JP2013519717 A5 JP 2013519717A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
variant
composition
bir01i
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012553390A
Other languages
English (en)
Japanese (ja)
Other versions
JP5926198B2 (ja
JP2013519717A (ja
Filing date
Publication date
Priority claimed from GBGB1002559.1A external-priority patent/GB201002559D0/en
Application filed filed Critical
Publication of JP2013519717A publication Critical patent/JP2013519717A/ja
Publication of JP2013519717A5 publication Critical patent/JP2013519717A5/ja
Application granted granted Critical
Publication of JP5926198B2 publication Critical patent/JP5926198B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012553390A 2010-02-15 2011-02-15 カバノキアレルギーに対するワクチン用ペプチド Expired - Fee Related JP5926198B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1002559.1 2010-02-15
GBGB1002559.1A GB201002559D0 (en) 2010-02-15 2010-02-15 Birch peptides for vaccine
PCT/GB2011/000206 WO2011098778A2 (en) 2010-02-15 2011-02-15 Peptides for vaccines against birch allergy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016042511A Division JP2016166194A (ja) 2010-02-15 2016-03-04 カバノキアレルギーに対するワクチン用ペプチド

Publications (3)

Publication Number Publication Date
JP2013519717A JP2013519717A (ja) 2013-05-30
JP2013519717A5 true JP2013519717A5 (cg-RX-API-DMAC7.html) 2014-04-03
JP5926198B2 JP5926198B2 (ja) 2016-05-25

Family

ID=42110757

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553390A Expired - Fee Related JP5926198B2 (ja) 2010-02-15 2011-02-15 カバノキアレルギーに対するワクチン用ペプチド
JP2016042511A Pending JP2016166194A (ja) 2010-02-15 2016-03-04 カバノキアレルギーに対するワクチン用ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016042511A Pending JP2016166194A (ja) 2010-02-15 2016-03-04 カバノキアレルギーに対するワクチン用ペプチド

Country Status (20)

Country Link
US (2) US9017689B2 (cg-RX-API-DMAC7.html)
EP (2) EP3056213A1 (cg-RX-API-DMAC7.html)
JP (2) JP5926198B2 (cg-RX-API-DMAC7.html)
KR (1) KR20120120965A (cg-RX-API-DMAC7.html)
CN (1) CN102762225B (cg-RX-API-DMAC7.html)
AU (1) AU2011214104B2 (cg-RX-API-DMAC7.html)
CA (2) CA2789353A1 (cg-RX-API-DMAC7.html)
DK (1) DK2536429T3 (cg-RX-API-DMAC7.html)
EA (1) EA201290792A1 (cg-RX-API-DMAC7.html)
ES (1) ES2573651T3 (cg-RX-API-DMAC7.html)
GB (2) GB201002559D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20160481T1 (cg-RX-API-DMAC7.html)
HU (1) HUE029138T2 (cg-RX-API-DMAC7.html)
IL (1) IL221196A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012009431A (cg-RX-API-DMAC7.html)
NZ (1) NZ602380A (cg-RX-API-DMAC7.html)
PL (1) PL2536429T3 (cg-RX-API-DMAC7.html)
SG (1) SG183198A1 (cg-RX-API-DMAC7.html)
SI (1) SI2536429T1 (cg-RX-API-DMAC7.html)
WO (1) WO2011098778A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201002559D0 (en) * 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
WO2013119853A1 (en) * 2012-02-07 2013-08-15 La Jolla Institute For Allergy And Immunology Epitopes from allergen proteins and methods and uses for immune response modulation
GB201209862D0 (en) 2012-06-01 2012-07-18 Circassia Ltd Cladosporium peptides
GB201211586D0 (en) * 2012-06-29 2012-08-15 Circassia Ltd Japanese cedar peptides for preventing or treating allergy
US20150088644A1 (en) 2013-09-23 2015-03-26 Facebook, Inc., a Delaware corporation Predicting User Interactions With Objects Associated With Advertisements On An Online System
CN106699584B (zh) * 2016-12-30 2018-06-26 南京农业大学 一种利用花粉作为天然催化剂制备的γ-氨基丁酸及其制备方法和应用
IL270894B2 (en) 2017-06-01 2023-04-01 Regeneron Pharma Human antibodies to bet v 1 and methods of using them
CN110175468B (zh) * 2019-05-05 2020-12-01 浙江工业大学 一种保留分布特征的姓名脱敏方法
CN115633666B (zh) * 2021-07-19 2025-11-18 四川大学华西医院 人源化双致敏动物模型和系统性过敏动物模型的构建方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
US5968526A (en) 1994-04-14 1999-10-19 Immulogic Pharamaceutical Corporation T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
JP2002500198A (ja) 1998-01-09 2002-01-08 サーカシア リミテッド 脱感作のための方法及び組成物
FR2788698B1 (fr) 1999-01-27 2001-03-30 Commissariat Energie Atomique Peptides et proteines aptes a desensibiliser les sujets allergiques au venin d'abeille et compositions les contenant
WO2003047618A2 (en) 2001-12-05 2003-06-12 Circassia Limited Immunotherapeutic methods and systems
ES2244708T3 (es) 2002-09-27 2005-12-16 Biomay Produktions- Und Handels- Aktiengesellschaft Vacunas hipoalergenicas contra la alergia basadas en el alergeno phl p 7 de polen de cola de zorro.
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
US20110038881A1 (en) 2007-05-09 2011-02-17 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
BRPI0815395A2 (pt) 2007-08-15 2015-02-10 Circassia Ltd Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
US8821887B2 (en) 2008-08-15 2014-09-02 Circassia Limited T-cell antigen peptide from allergen for stimulation of IL-10 production
GB201002559D0 (en) * 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine

Similar Documents

Publication Publication Date Title
AU724333B2 (en) Immunomodulatory peptides of vespid antigen 5
JP5390742B2 (ja) アレルゲンペプチド断片を含む組成物
Rolland et al. Stylicins, a new family of antimicrobial peptides from the Pacific blue shrimp Litopenaeus stylirostris
US20210128719A1 (en) Modular antigen transportation molecules and uses thereof in animals
JP7320947B2 (ja) 新規な免疫原性CD1d結合ペプチド
CN101977929B (zh) 用于治疗变态反应的主要1类和2类螨变应原的低变应原性杂合蛋白
JP5788319B2 (ja) ブタクサアレルギーの治療用のAmba1ペプチド
US20060024334A1 (en) Immunotherapeutic methods and systems
US8821887B2 (en) T-cell antigen peptide from allergen for stimulation of IL-10 production
CA2293736C (en) Synthetic antibiotics
PT2397154E (pt) Péptidos para dessensibilização contra alergénios
JP2006520380A5 (cg-RX-API-DMAC7.html)
CN106132996B (zh) 经改良的模块化抗原转运分子及其用途
US10806776B2 (en) Method of treating fungal infection
Brigatte et al. Hyperalgesic and edematogenic effects of peptides isolated from the venoms of honeybee (Apis mellifera) and neotropical social wasps (Polybia paulista and Protonectarina sylveirae)
Stöcklin et al. Structural identification by mass spectrometry of a novel antimicrobial peptide from the venom of the solitary bee Osmia rufa (Hymenoptera: Megachilidae)
EP1517916B1 (fr) Sphéniscines et peptides analogues antimicrobiens pour la conservation des aliments
US20190361022A1 (en) Peptide MHCII Tetramers to Detect Endogenous Calnexin Specific CD4 T Cells
EP3209324A2 (en) Vaccine development against the poultry red mite dermanyssus gallinae
MX2011009862A (es) Oligopeptidos sinteticos diseñados a partir de cisteinproteasas de acaros y metodos para la produccion de anticuerpos policlonales igy para la deteccion de acaros intradomiciliarios.
US20150273050A1 (en) Formulations for Non-invasive Delivery of Active Proteins to an Animal or Human